Daily Dose Equities - Wall Street Analysis for Biomedical Research - Daily Dose Newsroom - Pluristem Therapeutics to Present at Three Conferences in April ($PSTI)

Daily Dose Newsroom Index

Top

Search Daily Dose & Film Annex

BIO SmartBrief

Daily Dose Newsletter

Monday

Mar262012

Pluristem Therapeutics to Present at Three Conferences in April ($PSTI)

DDE Editor

Pluristem Therapeutics Inc. (NasdaqCM: PSTI; TASE: PLTR) is a leading developer of placenta-based cell therapies. The company's patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a variety of local and systemic inflammatory diseases. PLX cells are grown using the company’s proprietary 3D micro-environmental technology and are an off-the-shelf product that requires no tissue matching or immune-suppression treatment prior to administration.

Pluristem has announced that The Company's Sr. VP of Corporate Development, William Prather RPh, MD, will present at three upcoming financial and scientific events in the U.S.

According to the press release, "Dr. Prather will be "outlining the progress that Pluristem has made on the development of its PLacental eXpanded (PLX) cell product candidates," as well as speaking about "the recently announced pre-clinical data on acute radiation syndrome (ARS) and acute myocardial infarction (AMI), the construction of Pluristem's state-of-the-art cell therapy manufacturing facility, as well as the company's strategy of partnering with pharmaceutical companies for the marketing of several of its potential cell therapies."

Below is the schedule of events where Pluristem will be delivering presentations:

Needham Healthcare Conference - April 3 at 2:00PM - 2:40PM in Henry New York Palace Hotel, Manhattan, New York City

Imperial Capital's Healthcare Investor Forum - April 17 at 10:15AM - 10:45AM, New York Palace Hotel, Manhattan, New York City

8th Stem Cell Summit - April 19 at 3:15PM - 5:45PM session and on April 20 at 10:45AM - noon session, Hyatt Harborside Hotel, Boston, MA

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

Post a New Comment

Enter your information below to add a new comment.

My response is on my own website »

Author:

Author Email (optional):

Author URL (optional):

Post:

↓ | ↑

Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

Copyright by Daily Dose Equities. All rights reserved. This website contains information and opinions based on data obtained from reliable sources, which is current as of the publication date, and does not constitute a recommendation that any of the securities mentioned herein are appropriate for any specific individual circumstances and does not guarantee that future results or performance will match those predicted to occur. Although every effort is made to ensure the accuracy and completeness of the information on this website by using reliable data sources such as SEC filings and press releases, no guarantees are made in this regard as it has not been reviewed or certified by an independent auditor and may also include the opinions and future projections of the author. The contributing authors on this website are not chartered financial analysts, registered investment advisors or broker/dealers, and do not provide individual investment advice. The information provided by the writers on this website is for informational purposes only and should not be construed as an offer to buy or sell or a solicitation of an offer to buy or sell any financial instruments or to participate in any particular trading strategy in any jurisdiction. The information appearing on this website, blog, and related publications has not been reviewed or endorsed by any of the companies mentioned and should not be regarded as offical corporate news, publications, or shareholder communications. Film Annex Capital Partners, LLC (FACP) is the owner of this website and they provide strategic advisory, social media, and marketing services to emerging-growth companies. A number of the companies displayed on this site may be current or previous clients of FACP. In most instances, FACP has received fees for services for the creation, preparation and distribution of materials featured on this site, which are paid for in cash and/or stock, by the featured company ("client"). More detailed disclosure regarding fees paid is available upon request. FACP is not a broker/dealer or registered investment advisor. Information contained throughout this site is not an offer to buy or sell securities. Information presented on this site is solely for informative purposes, and is not intended, nor should they be construed, as investment advice. The information provided including news, blogs, corporate profiles, and other material is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country. The companies featured on this site are typically development-stage and investment in such securities is considered highly speculative and carries a high degree of risk. Complete loss of capital is a distinct possibility. We encourage our readers to invest carefully and read the investor information available at the web sites of the U.S. Securities and Exchange Commission (SEC) at www.sec.gov and the Financial Industry Regulatory Authority (FINRA) at www.finra.org. Opinions stated herein may be solely FACP or the indicated source's, and not necessarily those of the featured Company. Officers, directors, and employees of FACP and financial analysts mentioned, and/or members of their families, may hold a position and may, from time to time, trade in these securities for their own accounts. Specific information in this regard will be furnished upon request. Trademarks are the property of their respective owners. 2010-12 Film Annex Capital Partners, LLC. All rights reserved.